MDT
MedtronicCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Medtronic is showing that portfolio breadth can still compound: Q4 organic growth was 6.6%, Cardiac Ablation Solutions grew 78%, cardiovascular and medical-surgical were both strong, and the company added several regulatory and commercial milestones that can support FY27 momentum [#SEC-8K-2026-06-03].
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.4.
What can break
A strong Q4 can be harder to repeat, so any slowdown in cardiovascular or ablation momentum could pressure the post-earnings rerating.
Momentum
25
Value
59
Sentiment
65
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $103.00 · Bull $118.00 · Bear $72.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $96.70
Why
Momentum25 · Δ7d +6.5
Value59 · Δ7d +0.4
Sentiment65 · Δ7d -2.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
25
26% active weight
Current posture
7d trendImproving
Δ7d
+6.5
Δ21d
+5.0
Value
59
39% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.3
Sentiment
65
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.7
Δ21d
-4.1
Why this grade
Composite grade C. Momentum 25.1 / Value 59.2 / Sentiment 64.8
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$106.5B
Beta
0.72
Shares Out
1.28B
P/E (TTM)
26.3
P/S (TTM)
3.59
P/FCF (TTM)
78.40
Rev YoY
+9.9%
EPS YoY
+17.6%
Gross Margin
+60.3%
Op Margin
+17.9%
Net Debt
$19.93B
Current Ratio
2.13
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology